Mechanism
A thymic peptide doing exactly what the thymus does: training up your T-cells, waking up dendritic cells, putting natural killer cells to work. It leans your whole Th1/Th2 balance toward fighting off viruses and tumors instead of sitting there.
Key Benefit
Approved in 35+ countries for hepatitis B/C and as cancer immunotherapy adjunct. Used as immune booster in chronic infection and immunosenescence.
Evidence Base
Approved abroad, as Zadaxin, in more than 35 countries. Multiple human trials behind it too, covering hepatitis, cancer as an add-on therapy, and sepsis. The one country where it's not approved: the United States.
Route & Rationale
Subcutaneous injection. Peptide requires parenteral delivery for systemic immune modulation.
Interactions
Caution in autoimmune conditions. Immune stimulation may worsen flares. Otherwise well-tolerated.
Regulatory Status
Not FDA-approved here. Approved in more than 35 countries as Zadaxin. You can get it through a compounding pharmacy in the meantime.
Cautions
Autoimmune condition
For information and research purposes only. This is not medical advice and not a recommendation to use this substance. Discuss anything here with your healthcare provider.